Pilot Study to Examine the Acute Impact of Veillonella Supplementation on Exercise and Lactate Responses (VP)
Lactate Blood Increase, Exhaustion - Physiological
About this trial
This is an interventional treatment trial for Lactate Blood Increase focused on measuring Blood Lactate, Physiological Exhaustion, Exercise
Eligibility Criteria
Inclusion Criteria: Provide voluntary signed and dated informed consent. Be in good health as determined by medical history and routine blood chemistries. Age between 18 and 50 Exercises > 150 mins/week Body Mass Index of 18.5-29.9 and Body Fat of 30% Normotensive (seated, resting systolic blood pressure < 140 mm Hg and diastolic blood pressure < 90 mm Hg. If the first measurement is slightly elevated above these limits, the subject will be given a brief (5 minute) rest period, and two more measurements will be taken. The average of all three measurements will be used to determine eligibility. Normal seated, resting heart rate (< 90 beats per minute). Willing to follow all study protocols. Exclusion Criteria: Individuals currently diagnosed or being treated for any cardiac, respiratory, endocrine, psychiatric, musculoskeletal, renal, hepatic, neuromuscular or metabolic disease or disorder that in the judgement of the study participant's personal physician or research nurse that will preclude their safe participation or will contraindicate quality control over the collected data Individuals currently diagnosed with or are being treated for celiac disease, lactose intolerance, digestive insufficiencies or other gastrointestinal complications such as irritable bowel syndrome, ulcerative colitis, etc. Alcohol consumption (more than 2 standard alcoholic drinks per day or more than 10 drinks per week) or drug abuse or dependence. Smokers or individuals who have quit smoking within the last 6 months Known sensitivity to any ingredient in the test formulations as listed in the Nutrition Facts label. Individuals who are determined to be on a ketogenic diet. Individuals who are cognitively impaired and/or who are unable to give informed consent. Individuals taking a medication known to impact digestive function or hormonal functions that may impact how our body digests, absorbs, or metabolizes nutrients Individuals currently taking a probiotic or a dietary supplement that may impact digestive function or hormonal functions that may impact how our body digests, absorbs, or metabolizes nutrients Pregnant women, women trying to become pregnant, or nursing women. Participants who indicate they are actively restricting calories or attempting to lose weight. Individuals who do not participate in aerobic exercise > 2 days/week Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose a significant risk to the subject.
Sites / Locations
- Exercise and Performance Nutrition Laboratory
Arms of the Study
Arm 1
Arm 2
Placebo Comparator
Experimental
Placebo
Veillonella atypica FB004
14 days of supplementation placebo (maltodextrin)
14 days of supplementation 1 x 109CFU dose Veillonella atypica FB004